Form 4: Cargo Therapeutics Director, Reid M. Huber, Acquires Stock Options
SEC Form 4 Filing
Reid M. Huber, a director at Cargo Therapeutics, acquired stock options for 23,742 shares of common stock on June 4, 2024.
Summary
- On June 4, 2024, Reid M. Huber, a director of Cargo Therapeutics, Inc., acquired stock options for 23,742 shares of the company's common stock.
- The exercise price of these options is $19.17 per share.
- The options vest on the earlier of June 4, 2025, or the next Annual Meeting following June 4, 2024, contingent upon Huber's continued service to the Issuer.
- The options expire on June 3, 2034.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding stock option grants, which is neutral in sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director can be seen as a positive sign by shareholders, indicating confidence in the company's future performance.
Key Dates
| Date | Description |
|---|---|
| 06/04/2024 | Date of the stock option transaction. |
| 06/04/2024 | Vesting Commencement Date. |
| 06/04/2025 | One year anniversary of Vesting Commencement Date, potential vesting date. |
| 06/03/2034 | Expiration date of the stock options. |
| 06/06/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.